Trontinemab

• CAT Number: I040846
• CAS Number: 2568868-35-7
• Purity: ≥95%

Trontinemab is a bispecific and humanizedized IgG1-κ antibody, targeting to amyloid beta A4 precursor protein (APP) and transferrin receptor, p90, CD71 (TFRC). Trontinemab can be used for research on Alzheimer disease (AD)[1][2].

Reference

[1]. Duggan MR, et al. Herpes Viruses in the Baltimore Longitudinal Study of Aging: Associations With Brain Volumes, Cognitive Performance, and Plasma Biomarkers. Neurology. 2022 Aug 19;99(18):e2014–24.
 [Content Brief]

[2]. Trontinemab. IMGT/mAb-DB.